Physician profile
Lea A Singzon
NPI 1396066692
$1,101.34
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $878 · 2020: $210 · 2021: $12.88.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $250.50 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $195.65 | 2019-2020 | |
| Pfizer INC. | $91.73 | 2019-2020 | |
| Glaxosmithkline, LLC. | $66.29 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $54.96 | 2019-2020 | |
| Astellas Pharma US INC | $50.26 | 2019 | |
| Amarin Pharma, INC. | $48.96 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $47.32 | 2019-2020 | |
| Lilly USA, LLC | $43.06 | 2019-2020 | |
| Novo Nordisk INC | $40.46 | 2019 | |
| Daiichi Sankyo INC. | $34.24 | 2019 | |
| Mylan Specialty L.P. | $31.10 | 2019 | |
| Novartis Pharmaceuticals Corporation | $25.31 | 2019 | |
| Janssen Pharmaceuticals, INC | $21.86 | 2019 | |
| Ethicon US, LLC | $18.24 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $16.60 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.55 | 2020 | |
| Esperion Therapeutics, INC. | $12.88 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.66 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.53 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.18 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lea Singzon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.